Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb 21:11:40.
doi: 10.1186/1477-7819-11-40.

The effect of alkaline phosphatase and intrahepatic metastases in large hepatocellular carcinoma

Jong Man Kim  1 , Choon Hyuck David Kwon, Jae-Won Joh, Jae Berm Park, Justin Sangwook Ko, Joon Hyeok Lee, Sung Joo Kim, Cheol-Keun Park
Affiliations

The effect of alkaline phosphatase and intrahepatic metastases in large hepatocellular carcinoma

Jong Man Kim et al. World J Surg Oncol. .

Abstract

Background: Hepatectomy is the standard treatment for HCC. However, large HCC poses a difficult challenge because of the technical complexity of surgical resection and the fear of postoperative hepatic decompensation. We analyzed the outcome and prognostic factors in patients with large hepatocellular carcinoma (HCC ≥10 cm) after surgery.

Methods: We retrospectively investigated the medical records of 91 patients who had undergone hepatectomy between January 2006 and June 2010. A survival analysis was performed utilizing the Kaplan-Meier method and prognostic factors were evaluated using Cox regression analysis.

Results: Of the 91 patients evaluated, most tumors were associated with hepatitis B virus (HBV). The median tumor size was 12.3 cm (range, 10 to 21 cm), with microvascular invasion present in most patients. The postoperative mortality rate was 2.2%. The median disease-free survival and overall survival were six months and 41 months. The one-year, two-year, and three-year disease-free survival rates were 33.5%, 29.3%, and 18.8%, respectively. The one-year, two-year, and three-year overall survival rates were 73.9%, 63.7%, and 54.8%, respectively. Of the 89 surviving patients, 69 patients (77.5%) developed HCC recurrence during the mean follow-up period of 23.4 ± 15.9 months. On multivariate analysis, the statistically significant factors that predicted HCC recurrence were ALP ≥ 80 IU/mL (P = 0.009) and intrahepatic metastases (P = 0.013).

Conclusions: Our study suggests that preoperative ALP levels (≥ 80 IU/L) and intrahepatic metastases could be utilized to monitor and predict recurrence in HCC patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Disease-free survival and overall survival curves for patients who underwent hepatic resection of hepatocellular carcinoma larger than 10 cm in diameter.
Figure 2
Figure 2
(A) Influence of ALP levels and (B) intrahepatic metastasis on disease-free survival.
Figure 3
Figure 3
(A) Disease free survival and (B) overall survival in patients with no risk factors when compared with those who had at least one risk factor.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Chen XP, Qiu FZ, Wu ZD, Zhang BX. Chinese experience with hepatectomy for huge hepatocellular carcinoma. Br J Surg. 2004;91:322–326. doi: 10.1002/bjs.4413. - DOI - PubMed
    1. Choi GH, Han DH, Kim DH, Choi SB, Kang CM, Kim KS, Choi JS, Park YN, Park JY, Kim do Y. Outcome after curative resection for a huge (≥ 10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification. Am J Surg. 2009;198:693–701. doi: 10.1016/j.amjsurg.2008.09.019. - DOI - PubMed
    1. Pandey D, Lee KH, Wai CT, Wagholikar G, Tan KC. Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection. Ann Surg Oncol. 2007;14:2817–2823. doi: 10.1245/s10434-007-9518-1. - DOI - PubMed
    1. Poon RT, Ngan H, Lo CM, Liu CL, Fan ST, Wong J. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol. 2000;73:109–114. doi: 10.1002/(SICI)1096-9098(200002)73:2<109::AID-JSO10>3.0.CO;2-J. - DOI - PubMed
    1. Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I, Yamaoka Y, Belghiti J, Lauwers GY, Poon RT, Abdalla EK. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005;11:1086–1092. doi: 10.1002/lt.20472. - DOI - PubMed

MeSH terms

Substances